Global Antibody Therapeutics and Blood Antibody Therapeutics Competitive Landscape Professional Research Report 2024

Research Summary

Antibody therapy refers to a specific type of medicine that uses antibodies to fight or prevent disease. Antibodies are proteins produced by the immune system that recognize and bind to specific molecules (called antigens) to trigger an immune response. Scientists have developed techniques to generate monoclonal antibodies that can be produced in large quantities and used as drugs to treat a variety of diseases, including cancer, autoimmune diseases and infectious diseases. Blood antibody therapy usually refers to the use of plasma containing high levels of antibody molecules, called convalescent plasma, which is obtained from people who have recovered from a particular disease. This plasma can be infused into patients currently infected with the same disease to provide passive immunity to help them fight infection.

According to DIResearch's in-depth investigation and research, the global Antibody Therapeutics and Blood Antibody Therapeutics market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Antibody Therapeutics and Blood Antibody Therapeutics include Roche, Abbvie, Johnson & Johnson, Bristol-Myers Squibb, Novartis, Merck, Alexion Pharmaceuticals, Takeda, Amgen, Biogen, Eli Lilly and Company, UCB, AstraZeneca etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Antibody Therapeutics and Blood Antibody Therapeutics. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Antibody Therapeutics and Blood Antibody Therapeutics market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Antibody Therapeutics and Blood Antibody Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Antibody Therapeutics and Blood Antibody Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Antibody Therapeutics and Blood Antibody Therapeutics Include:

Roche

Abbvie

Johnson & Johnson

Bristol-Myers Squibb

Novartis

Merck

Alexion Pharmaceuticals

Takeda

Amgen

Biogen

Eli Lilly and Company

UCB

AstraZeneca

Antibody Therapeutics and Blood Antibody Therapeutics Product Segment Include:

IgG1

IgG4

Others

Antibody Therapeutics and Blood Antibody Therapeutics Product Application Include:

Autoimmune

Tumor

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Antibody Therapeutics and Blood Antibody Therapeutics Industry PESTEL Analysis

Chapter 3: Global Antibody Therapeutics and Blood Antibody Therapeutics Industry Porter's Five Forces Analysis

Chapter 4: Global Antibody Therapeutics and Blood Antibody Therapeutics Major Regional Market Size and Forecast Analysis

Chapter 5: Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Antibody Therapeutics and Blood Antibody Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Antibody Therapeutics and Blood Antibody Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Antibody Therapeutics and Blood Antibody Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Antibody Therapeutics and Blood Antibody Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Antibody Therapeutics and Blood Antibody Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Antibody Therapeutics and Blood Antibody Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Antibody Therapeutics and Blood Antibody Therapeutics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Antibody Therapeutics and Blood Antibody Therapeutics Market Overview

1.1 Product Definition and Statistical Scope

1.2 Antibody Therapeutics and Blood Antibody Therapeutics Product by Type

1.2.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 IgG1

1.2.3 IgG4

1.2.4 Others

1.3 Antibody Therapeutics and Blood Antibody Therapeutics Product by Application

1.3.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Autoimmune

1.3.3 Tumor

1.3.4 Others

1.4 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Revenue Analysis (2019-2030)

1.5 Antibody Therapeutics and Blood Antibody Therapeutics Market Development Status and Trends

1.5.1 Antibody Therapeutics and Blood Antibody Therapeutics Industry Development Status Analysis

1.5.2 Antibody Therapeutics and Blood Antibody Therapeutics Industry Development Trends Analysis

2 Antibody Therapeutics and Blood Antibody Therapeutics Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Antibody Therapeutics and Blood Antibody Therapeutics Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Analysis by Regions

4.1 Antibody Therapeutics and Blood Antibody Therapeutics Overall Market: 2023 VS 2024 VS 2030

4.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue and Market Share by Region (2019-2024)

4.2.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Revenue Forecast by Region (2025-2030)

5 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type and Application

5.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type

5.2 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application

6 North America

6.1 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type

6.4 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application

6.5 North America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type

7.4 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application

7.5 Europe Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type

8.4 China Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type

9.4 APAC (excl. China) Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application

9.5 APAC (excl. China) Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type

10.4 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application

10.5 Latin America Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Type

11.4 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Application

11.5 Middle East & Africa Antibody Therapeutics and Blood Antibody Therapeutics Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Antibody Therapeutics and Blood Antibody Therapeutics Market Revenue by Key Manufacturers (2020-2024)

12.2 Antibody Therapeutics and Blood Antibody Therapeutics Competitive Landscape Analysis and Market Dynamic

12.2.1 Antibody Therapeutics and Blood Antibody Therapeutics Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 Roche

13.1.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 Roche Antibody Therapeutics and Blood Antibody Therapeutics Product Portfolio

13.1.3 Roche Antibody Therapeutics and Blood Antibody Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Abbvie

13.2.1 Abbvie Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Product Portfolio

13.2.3 Abbvie Antibody Therapeutics and Blood Antibody Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Johnson & Johnson

13.3.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Product Portfolio

13.3.3 Johnson & Johnson Antibody Therapeutics and Blood Antibody Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Bristol-Myers Squibb

13.4.1 Bristol-Myers Squibb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Product Portfolio

13.4.3 Bristol-Myers Squibb Antibody Therapeutics and Blood Antibody Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Novartis

13.5.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Novartis Antibody Therapeutics and Blood Antibody Therapeutics Product Portfolio

13.5.3 Novartis Antibody Therapeutics and Blood Antibody Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Merck

13.6.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Merck Antibody Therapeutics and Blood Antibody Therapeutics Product Portfolio

13.6.3 Merck Antibody Therapeutics and Blood Antibody Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Alexion Pharmaceuticals

13.7.1 Alexion Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Product Portfolio

13.7.3 Alexion Pharmaceuticals Antibody Therapeutics and Blood Antibody Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Takeda

13.8.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Takeda Antibody Therapeutics and Blood Antibody Therapeutics Product Portfolio

13.8.3 Takeda Antibody Therapeutics and Blood Antibody Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Amgen

13.9.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Amgen Antibody Therapeutics and Blood Antibody Therapeutics Product Portfolio

13.9.3 Amgen Antibody Therapeutics and Blood Antibody Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Biogen

13.10.1 Biogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Biogen Antibody Therapeutics and Blood Antibody Therapeutics Product Portfolio

13.10.3 Biogen Antibody Therapeutics and Blood Antibody Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Eli Lilly and Company

13.11.1 Eli Lilly and Company Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Product Portfolio

13.11.3 Eli Lilly and Company Antibody Therapeutics and Blood Antibody Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 UCB

13.12.1 UCB Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 UCB Antibody Therapeutics and Blood Antibody Therapeutics Product Portfolio

13.12.3 UCB Antibody Therapeutics and Blood Antibody Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 AstraZeneca

13.13.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Product Portfolio

13.13.3 AstraZeneca Antibody Therapeutics and Blood Antibody Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Antibody Therapeutics and Blood Antibody Therapeutics Industry Chain Analysis

14.2 Antibody Therapeutics and Blood Antibody Therapeutics Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Antibody Therapeutics and Blood Antibody Therapeutics Typical Downstream Customers

14.4 Antibody Therapeutics and Blood Antibody Therapeutics Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support